Your browser doesn't support javascript.
loading
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.
Menzies, A M; Johnson, D B; Ramanujam, S; Atkinson, V G; Wong, A N M; Park, J J; McQuade, J L; Shoushtari, A N; Tsai, K K; Eroglu, Z; Klein, O; Hassel, J C; Sosman, J A; Guminski, A; Sullivan, R J; Ribas, A; Carlino, M S; Davies, M A; Sandhu, S K; Long, G V.
  • Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Johnson DB; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Ramanujam S; Vanderbilt University Medical Center, Nashville, USA.
  • Atkinson VG; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Wong ANM; Princess Alexandra Hospital, Greenslopes Hospital and University of Queensland, Brisbane, Australia.
  • Park JJ; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • McQuade JL; Crown Princess Mary Cancer Centre Westmead, Sydney, Australia.
  • Shoushtari AN; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Tsai KK; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Eroglu Z; Department of Medical Oncology, University of California San Francisco, San Francisco, USA.
  • Klein O; Department of Medical Oncology, Moffitt Cancer Centre, Tampa, USA.
  • Hassel JC; Department of Medical Oncology, Olivia Newton-John Cancer Centre & Cancer Research Institute, Austin Health, Melbourne, Australia.
  • Sosman JA; Department of Dermatology, Heidelberg University, Heidelberg, Germany.
  • Guminski A; Vanderbilt University Medical Center, Nashville, USA.
  • Sullivan RJ; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Ribas A; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Carlino MS; Massachusetts General Hospital Cancer Center, Boston, USA.
  • Davies MA; Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, USA.
  • Sandhu SK; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Long GV; Crown Princess Mary Cancer Centre Westmead, Sydney, Australia.
Ann Oncol ; 28(2): 368-376, 2017 02 01.
Article en En | MEDLINE | ID: mdl-27687304
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias Encefálicas / Anticuerpos Monoclonales Humanizados / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma / Anticuerpos Monoclonales Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias Encefálicas / Anticuerpos Monoclonales Humanizados / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma / Anticuerpos Monoclonales Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article